- Home
- IMXI vs ARCT Comparison
IMXI vs ARCT Comparison
Compare IMXI & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMXI | ARCT |
|---|---|---|
| Founded | 1994 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 458.3M | 194.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IMXI | ARCT |
|---|---|---|
| Price | $15.34 | $6.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | $16.67 | ★ $38.67 |
| AVG Volume (30 Days) | 219.6K | ★ 681.4K |
| Earning Date | 11-10-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $625,123,000.00 | $97,601,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.95 | N/A |
| P/E Ratio | $11.90 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.58 | $5.85 |
| 52 Week High | $21.41 | $24.17 |
Technical Indicators
Market Signals| Indicator | IMXI | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 53.75 | 35.13 |
| Support Level | $15.32 | $6.02 |
| Resistance Level | $15.43 | $6.75 |
| Average True Range (ATR) | 0.05 | 0.31 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 7.89 | 13.13 |
Price Performance
Historical ComparisonAbout IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.